Myomo (MYO) Interest Coverage Ratio Growth (1y) (2017 - 2025)
Myomo (MYO) Interest Coverage Ratio Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | -54.61% |
| 10 | Myomo | 42.89 Mn | 23.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 68.06% |
| Jun 30, 2025 | 78.14% |
| Mar 31, 2025 | -81.61% |
| Dec 31, 2024 | 82.02% |
| Sep 30, 2024 | 55.01% |
| Jun 30, 2024 | -136.07% |
| Mar 31, 2024 | -234.15% |
| Dec 31, 2023 | 99.72% |
| Sep 30, 2023 | 34.92% |
| Jun 30, 2023 | 6.82% |
| Mar 31, 2023 | -99.27% |
| Dec 31, 2022 | -3,155.60% |
| Sep 30, 2022 | -547.84% |
| Jun 30, 2022 | 80.85% |
| Mar 31, 2022 | 73.07% |
| Sep 30, 2021 | 75.95% |
| Jun 30, 2021 | 35.55% |
| Mar 31, 2021 | 52.94% |
| Sep 30, 2020 | 80.41% |
| Dec 31, 2019 | -744.05% |